The ISPOR good practice modeling principles - A sensible approach: Be transparent, be reasonable

Value in Health

Volumn 6, Issue 1, 2003, Pages 6-8

  Garrison Jr , Louis P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; EDITORIAL; GOOD LABORATORY PRACTICE; HUMAN; INFORMATION; LEADERSHIP; MODEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD;

EID: 0037286008     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2003.00003.x     Document Type: Editorial

References (4)

1. Weinstein M, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2003;6:9-17.
2. Gold MR, Siegel JE, Russell LB, et al., editors. Cost- Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
3. Pauly M. Guidelines for pharmacoeconomics studies. Conference paper: Policy Issues in Pharmaceutical Cost-Effectiveness Research. American Enterprise Institute, Washington, D.C., 1996;Nov 20.
4. Drummond M. Time for a change in drug licensing requirements? Eur J Health Econ 2002;3:137-8.